Merck (MRK) Announces U.K. NICE Draft Recommendation for KEYTRUDA as Advanced Melanoma Treatment
Tweet Send to a Friend
Merck (NYSE: MRK) announced the National Institute for Health and Care Excellence (NICE) of the United Kingdom (U.K.) has issued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
